Cargando…

66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014

Burkholderia cepacia complex (Bcc) is recognized as a significant respiratory pathogen in Cystic Fibrosis (CF) patients. The identification at species level among the 18 established Bcc members is an essential tool for epidemiological studies and infection control policies. In the early 2000s the ep...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibarra, L., Degrossi, J., Vargas, L. Jordá, Barrero, P., Vazquez, M., Teper, A., Galanternik, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Cystic Fibrosis Society. Published by Elsevier B.V. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128932/
http://dx.doi.org/10.1016/S1569-1993(15)30243-5
_version_ 1783516674875457536
author Ibarra, L.
Degrossi, J.
Vargas, L. Jordá
Barrero, P.
Vazquez, M.
Teper, A.
Galanternik, L.
author_facet Ibarra, L.
Degrossi, J.
Vargas, L. Jordá
Barrero, P.
Vazquez, M.
Teper, A.
Galanternik, L.
author_sort Ibarra, L.
collection PubMed
description Burkholderia cepacia complex (Bcc) is recognized as a significant respiratory pathogen in Cystic Fibrosis (CF) patients. The identification at species level among the 18 established Bcc members is an essential tool for epidemiological studies and infection control policies. In the early 2000s the epidemiology of Burkholderia cepacia (Bcc) in Argentina was characterized by the occurrence of a B. contaminans outbreak that took place in major CF centres. This situation was quite different from other countries where B. cenocepacia and B. multivorans have been the most frequent Bcc infecting species in CF patients. Although B. contaminans outbreak was studied, little is known about the evolution of Bcc epidemiology during the last years. The aim of this study was to analyse Bcc infections in CF patients (pt) attending Hospital de Niños “R. Gutiérrez” in 3 different periods between 2004 and 2014. Incidence and distribution of Bcc species have been described. 2004–2005: Incidence 13.5% (22/163 pt). B. contaminans 55.6% (10/18), B. cepacia 16.7% (3/18), B. cenocepacia and B. seminalis 11.1% (2/18), B. multivorans 5.6% (1/18), 4 nonviable strains. 2007–2009: Incidence 6.6% (12/181 pt). B. contaminans 72.7% (8/11), B. cepacia 27.3% (3/11), 1 nonviable strain. 2012–2014: Incidence 5.4% (10/184 pt). B. contaminans 90% (9/10), B. cepacia 10% (1/10). CONCLUSION: B. contaminans remains the most frequent isolated species among the new cases of infection. Although incidence values have decreased, these results suggest the situation with B. contaminans hasn't been solved yet. More studies specially focusing on the transmission of these bacteria and the possible sources of infection are needed.
format Online
Article
Text
id pubmed-7128932
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher European Cystic Fibrosis Society. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71289322020-04-08 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014 Ibarra, L. Degrossi, J. Vargas, L. Jordá Barrero, P. Vazquez, M. Teper, A. Galanternik, L. J Cyst Fibros Posters Burkholderia cepacia complex (Bcc) is recognized as a significant respiratory pathogen in Cystic Fibrosis (CF) patients. The identification at species level among the 18 established Bcc members is an essential tool for epidemiological studies and infection control policies. In the early 2000s the epidemiology of Burkholderia cepacia (Bcc) in Argentina was characterized by the occurrence of a B. contaminans outbreak that took place in major CF centres. This situation was quite different from other countries where B. cenocepacia and B. multivorans have been the most frequent Bcc infecting species in CF patients. Although B. contaminans outbreak was studied, little is known about the evolution of Bcc epidemiology during the last years. The aim of this study was to analyse Bcc infections in CF patients (pt) attending Hospital de Niños “R. Gutiérrez” in 3 different periods between 2004 and 2014. Incidence and distribution of Bcc species have been described. 2004–2005: Incidence 13.5% (22/163 pt). B. contaminans 55.6% (10/18), B. cepacia 16.7% (3/18), B. cenocepacia and B. seminalis 11.1% (2/18), B. multivorans 5.6% (1/18), 4 nonviable strains. 2007–2009: Incidence 6.6% (12/181 pt). B. contaminans 72.7% (8/11), B. cepacia 27.3% (3/11), 1 nonviable strain. 2012–2014: Incidence 5.4% (10/184 pt). B. contaminans 90% (9/10), B. cepacia 10% (1/10). CONCLUSION: B. contaminans remains the most frequent isolated species among the new cases of infection. Although incidence values have decreased, these results suggest the situation with B. contaminans hasn't been solved yet. More studies specially focusing on the transmission of these bacteria and the possible sources of infection are needed. European Cystic Fibrosis Society. Published by Elsevier B.V. 2015-06 2015-06-05 /pmc/articles/PMC7128932/ http://dx.doi.org/10.1016/S1569-1993(15)30243-5 Text en Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Posters
Ibarra, L.
Degrossi, J.
Vargas, L. Jordá
Barrero, P.
Vazquez, M.
Teper, A.
Galanternik, L.
66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title_full 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title_fullStr 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title_full_unstemmed 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title_short 66 Incidence of Burkholderia cepacia complex infection in a Cystic Fibrosis Centre in Buenos Aires City, Argentina, from 2004 to 2014
title_sort 66 incidence of burkholderia cepacia complex infection in a cystic fibrosis centre in buenos aires city, argentina, from 2004 to 2014
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128932/
http://dx.doi.org/10.1016/S1569-1993(15)30243-5
work_keys_str_mv AT ibarral 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT degrossij 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT vargasljorda 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT barrerop 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT vazquezm 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT tepera 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014
AT galanternikl 66incidenceofburkholderiacepaciacomplexinfectioninacysticfibrosiscentreinbuenosairescityargentinafrom2004to2014